Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPersimmon Regulatory News (PSN)

Share Price Information for Persimmon (PSN)

Share Price is delayed by 15 minutes
Get Live Data
1,078.50    26.00 (2.47%)
Bid:
1,071.00
Ask:
1,072.00
Spread: 1.00 (0.093%)
Market Cap: £3.46b
PSN Live PriceLast checked at - London Stock Exchange

Intraday Persimmon Share Chart

Trading Update

10 Jan 2011 07:00

RNS Number : 1355Z
Persimmon PLC
10 January 2011
 

Persimmon plc

 

TRADING UPDATE - 10 JANUARY 2011

 

 

Persimmon plc announces the following update ahead of its Preliminary Results for the year ended 31 December 2010, which will be released on Tuesday 1 March 2011.

 

For the year just ended we have achieved a significant increase in underlying profit before tax, which will be at the top end of analysts' expectations.(1)

 

During 2010 we have legally completed 9,384 (2009: 8,976) homes at an average selling price of c. £167,000 generating a turnover of c. £1.57 billion. This represents an increase on the 2009 performance of 4.5% on legal completions, a c. 6% improvement in average selling price of our homes, partly due to mix changes, and a c. 10% increase in turnover.

 

We have also achieved a further significant reduction in net borrowings to c. £51 million (31 December 2009: £267.5 million) during this period. This reduction in net borrowings is well ahead of original expectations and is a result of our continued strategy to generate cash whilst maximising margins. As previously indicated underlying operating margin for the year will be c. 8%.

 

In keeping with our current strategy we have continued to acquire new land through the remainder of the second half of the year on a selective basis and have acquired over 5,000 plots in the second half. We have c. 59,000 plots owned and under control in our landbank at 31 December 2010, which represents c. 6.3 years supply.

 

In our Interim Management Statement on 15 November 2010 we commented that we had not experienced the usual level of upturn in sales in the autumn period. Since that announcement most parts of the country have been affected by severe weather conditions for several weeks. Whilst, unsurprisingly, this has reduced the level of sales activity at our developments during the period, pricing has remained stable and the margins on our forward sales of c. £565 million have been maintained at the levels achieved over recent months.

 

We expect to open c. 70 new developments over the course of the next six months which will ensure our operating developments are maintained at current levels of c. 380 outlets. It is too early in the New Year to assess the likely outcome of the forthcoming Spring sales season. However, we believe that prospective purchasers who may have postponed visits to our developments due to the harsh weather conditions prior to the year end will return during the coming weeks.

 

We will give an update on our assessment of the housing market over the first weeks of 2011 when we announce our Results for the year ended 31 December 2010 on Tuesday 1 March 2011.

 

Finally, as confirmed in a separate announcement this morning, after 32 years with Persimmon John White has informed the Board of his decision to step down as Chairman of the company at the Annual General Meeting on 21 April 2011. He will be replaced by Nicholas Wrigley, who has been a Non-Executive Director since 2006 and is an Executive Vice Chairman of Rothschild, London.

 

 

Please Note

There will be a call for analysts at 9am GMT today. Please use the dial-in details below:

 

Telephone number: + 44 20 3059 5845

Conference code: Persimmon

 

 

For further information, please contact:

 

Edward Orlebar

Charlotte McMullen

Marylène Guernier

Mike Farley, Group Chief Executive

Mike Killoran, Group Finance Director

Persimmon plc

Tel: +44 (0) 20 7920 2369 on the day

M:Communications

Tel: +44 (0) 1904 642199 thereafter

Tel: +44 (0) 20 7920 2369

 

 

 

(1)  Note Analysts expectations for underlying profit before tax for the year ended 31 December 2010 range from £75m to £96m with a consensus of £85m. Underlying profit before tax is stated before goodwill charges and exceptional items

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTDMGGMVNRGMZM
Date   Source Headline
1st May 20257:00 amRNSAGM Trading Statement
25th Apr 202510:54 amRNSHolding(s) in Company
25th Apr 20259:24 amRNSHolding(s) in Company
11th Apr 20254:22 pmRNSHolding(s) in Company
3rd Apr 202510:15 amRNSHolding(s) in Company
2nd Apr 202512:22 pmRNSHolding(s) in Company
1st Apr 202512:03 pmRNSTotal Voting Rights
31st Mar 20253:14 pmRNSDirector/PDMR Shareholding
27th Mar 202510:08 amRNSHolding(s) in Company
25th Mar 20253:14 pmRNSDirector/PDMR Shareholding
24th Mar 20253:35 pmRNSAnnual Report 2024 and Notice of AGM 2025
24th Mar 20252:24 pmRNSHolding(s) in Company
11th Mar 20257:00 amRNSFull Year Results
6th Mar 20252:06 pmRNSHolding(s) in Company
3rd Mar 20253:35 pmRNSHolding(s) in Company
3rd Feb 202512:26 pmRNSTotal Voting Rights
14th Jan 20257:00 amRNS2024 Trading Statement
2nd Jan 20251:00 pmRNSTotal Voting Rights
10th Dec 20243:47 pmRNSDirectorate Change
2nd Dec 20242:11 pmRNSBlock listing Interim Review
2nd Dec 202412:00 pmRNSTotal Voting Rights
6th Nov 20247:00 amRNSQ3 Trading Statement
5th Nov 20241:31 pmRNSHolding(s) in Company
1st Nov 20243:59 pmRNSTotal Voting Rights
1st Oct 20241:19 pmRNSTotal Voting Rights
24th Sep 202412:25 pmRNSDirector/PDMR Shareholding
2nd Sep 20241:44 pmRNSTotal Voting Rights
8th Aug 20247:00 amRNSHalf Year Results
1st Aug 20242:32 pmRNSTotal Voting Rights
23rd Jul 202410:28 amRNSDirectorate Change
1st Jul 20241:10 pmRNSTotal Voting Rights
19th Jun 20242:48 pmRNSDirector/PDMR Shareholding
3rd Jun 202412:33 pmRNSBlock listing Interim Review
3rd Jun 202411:08 amRNSTotal Voting Rights
23rd May 20247:00 amRNSConfirmation of CFO start date
1st May 20241:11 pmRNSTotal Voting Rights
30th Apr 20242:03 pmRNSDirectorate Change
25th Apr 20242:09 pmRNSResult of AGM
25th Apr 20247:00 amRNSQ1 Trading Statement
2nd Apr 20241:49 pmRNSTotal Voting Rights
28th Mar 202412:53 pmRNSDirector/PDMR Shareholding
25th Mar 20244:47 pmRNSDirector/PDMR Shareholding
25th Mar 20242:07 pmRNSAnnual Report 2023 and Notice of AGM 2024
12th Mar 20241:38 pmRNSDirector/PDMR Shareholding
12th Mar 20247:00 amRNSFull Year Results
11th Jan 20246:00 pmRNSDechra Pharmaceuticals
10th Jan 20247:00 amRNSTrading Statement
1st Dec 20234:48 pmRNSBlock listing Interim Review
1st Dec 20234:45 pmRNSTotal Voting Rights
17th Nov 202310:25 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.